<ul class="summary-bullets"><li>Meanwhile, on Wednesday, the S&amp;P 500 and the Nasdaq Composite notched record highs for a second day in a row.</li><li>Oil futures climbed higher in Wednesday’s overnight session.&nbsp;</li><li>Treasury yields on the benchmark 10-year were at 4.344%, while gold traded around $4,711.24 an ounce.</li></ul>U.S. stock futures declined marginally in Wednesday’s overnight trading after President Donald Trump threatened a “much higher level” of bombings in Iran in case of failed negotiations, eclipsing the boost from artificial intelligence optimism.Dow Jones futures were about 0.10% lower at the time of writing, while the S&amp;P 500 futures were also down 0.10%, and Nasdaq 100 futures lost 0.23% as of 8.39 p.m ET. &nbsp;Among ETFs tracking benchmark indexes, the SPDR S&amp;P 500 ETF (SPY), Invesco QQQ Trust (QQQ), and the SPDR Dow Jones Industrial Average ETF Trust (DIA) were climbing higher. Meanwhile, retail sentiment on Stocktwits for three indexes was green.<h2 class="st-heading-2">How Did US Markets Fare?</h2>On Wednesday, the S&amp;P 500 and the Nasdaq Composite notched record highs for a second day in a row, climbing to 7,365.12 and 25,838.94, respectively. Meanwhile, the Dow Jones Industrial Average added more than 600 points to close 1.24% higher.<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>1.24%</td><td>49,910.59</td></tr><tr><td>S&amp;P 500</td><td>1.46%</td><td>7,365.12</td></tr><tr><td>Nasdaq Composite</td><td>2.02%</td><td>25,838.94</td></tr></tbody></table></figure></div><h2 class="st-heading-2">US Market Drivers</h2>U.S. stock markets soared on Wednesday as a deal with Iran seemed closer to completion after reports that Iran was considering a U.S. proposal to end the war.However, Trump later threatened an escalation of attacks on Iran if the Middle Eastern country did not agree to the deal from Washington.“Assuming Iran agrees to give what has been agreed to, which is, perhaps, a big assumption, the already legendary Epic Fury will be at an end, and the highly effective Blockade will allow the Hormuz Strait to be OPEN TO ALL, including Iran. If they don’t agree, the bombing starts, and it will be, sadly, at a much higher level and intensity than it was before,” Trump said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/116527444859592032">post</a> on Truth Social on Wednesday.Meanwhile, investors are looking out for earnings releases from top companies. Spectacular performances from blue-chip companies, especially in the technology and AI sectors, have bolstered the market this quarter. Results from CoreWeave Inc. (CRWV), Rocket Lab USA Inc. (RKLB), and Airbnb Inc. (ABNB), among others, are due on Thursday.Investors will also be looking out for jobs data and other employment-related updates on the economic front.<h2 class="st-heading-2">Trending Stocks To Watch</h2>Snap Inc. (SNAP): The social media company’s shares slipped by over 8% in extended trading hours after it reported its <a href="https://stocktwits.com/news-articles/markets/equity/snap-stock-tumbles-after-flagging-ad-revenue-hit-amid-iran-war/cZQzmJvReOU">first-quarter (Q1) results</a> and highlighted a substantial hit to its advertising revenues due to the Iran war.Arm Holdings Plc. (ARM): The company’s share prices slipped more than 6% despite a double beat in the <a href="https://stocktwits.com/news-articles/markets/equity/arm-stock-drops-after-ceo-flags-supply-risks-that-could-dent-new-semiconductor-chips-sales-in-q2/cZXGuvIReO6">fourth quarter</a> (Q4). However, the company flagged supply chain constraints that could affect its ability to meet demand, weighing on sentiment.Root Inc. (ROOT): The insurance carrier garnered attention after it posted a record net income of $36 million, nearly doubling year-over-year, in Q1 2026.Paramount Skydance Corp. (PSKY): The company was on the retail radar after Warner Bros. Discovery (WBD) reported Q1 results on Wednesday, amid the takeover deal.<h2 class="st-heading-2">Broader Market Trends</h2>Oil futures climbed higher in Wednesday’s overnight session. Brent crude futures expiring in July were up about 0.59%, trading at around $101.87 a barrel, while WTI crude futures expiring in June were up 0.64% to $95.69 a barrel at the time of writing.Treasury yields on the benchmark 10-year were at 4.344%, while gold traded around $4,711.24 an ounce.Asian markets were mixed at the open on Thursday. Japan’s Nikkei 225 breached the 62,000 mark for the first time, while the SSE Composite Index also climbed higher. The KOSPI was declining at the time of writing, while Australian stocks edged up higher at the open.For updates and corrections, email newsroom[at]stocktwits[dot]com.

President Trump Returns To Washington From Florida On Sunday. (Photo by Roberto Schmidt/Getty Images)

Dow, S&P 500, Nasdaq Futures Slip As Trump Threatens ‘Much Higher Level’ Of Bombing In Iran Deal Failure: SNAP, ARM, ROOT, PSKY Stocks In Focus Today

Trump on Wednesday threatened a “much higher level” of bombings on Iran, indicating a potential escalation of attacks if the country did not agree to the deal from Washington. 

Equity

<ul class="summary-bullets"><li>Beyond Meat said persistent volatility across its business environment continues to weigh on Q2 results.&nbsp;</li><li>The company’s Q1 revenue declined 15.3% year-on-year.&nbsp;</li><li>Beyond Meat is restructuring its business beyond plant-based meat, launching a multifunctional nutrition beverage called Beyond Immerse.&nbsp;</li></ul>Beyond Meat (BYND) stock plummeted 13% overnight on Thursday after the plant-based food maker posted another quarter of shrinking sales and warned that demand challenges are likely to continue through the current quarter.&nbsp;The sell-off erased part of the stock’s sharp 40% rebound in April, which had been fueled largely by speculative trading activity and elevated short interest.<h2 class="st-heading-2">BYND’s Outlook And Q1 Performance&nbsp;</h2>Beyond Meat said that ongoing instability in its operating environment has created unpredictable challenges that may continue to affect performance. It forecast second-quarter (Q2) 2026 revenue between $60 million and $65 million, below the analysts’ consensus estimate of $67.94 million, according to Fiscal AI data.&nbsp;Beyond Meat generated $58.2 million in Q1 revenue, down 15.3% year-on-year, inline with the analysts’ consensus estimate. The drop was mainly due to weaker sales of its burger and chicken products in retail stores and through restaurant partnerships.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Beyond_Meats_Shrinking_Revenue_jpg_9c77c3f232.webp" alt="Chart Showing BYND's Revenue.Source:Koyfin" width="2400" height="1701"><figcaption>Chart Showing BYND's Revenue.Source:Koyfin</figcaption></figure>The company reported a gross profit of $2 million, marking a notable improvement from the prior year’s gross loss of&nbsp;$6.9 million. Gross margin turned positive at 3.4%.&nbsp;Beyond Meat still posted a net loss of $28.5 million for the quarter, though that represented a major improvement from the $61.1 million loss reported last year.&nbsp;<h2 class="st-heading-2">BYND’s Strategic Expansion&nbsp;</h2>Beyond Meat has been broadening its strategy beyond plant-based meat to reverse declining sales and restore long-term growth. During the Q1 earnings call, Founder and CEO Ethan Brown outlined a restructuring plan centered on new product categories, tighter operational controls, and expanded distribution partnerships.One of the company’s biggest strategic&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/beyond-meat-cuts-the-meat-in-protein-drink-pivot/cZdhuqbRIES">changes</a> involves repositioning the brand simply as “Beyond” as it enters adjacent nutrition categories.&nbsp;“The first product to emerge from this broadened aperture is Beyond Immerse, a clear, lightly carbonated drink delivering protein, fiber, antioxidants, and electrolytes. One way to think about Beyond Immerse is to note that it is concurrently addressing four distinct beverage categories, each of which serve a specific need, protein drinks, fiber drinks, vitamin drinks, and electrolyte drinks,” said Brown.<h2 class="st-heading-2">What BYND Retail Traders Are Saying?&nbsp;</h2>On Stocktwits, retail sentiment around the stock swung to ‘bullish’ from ‘neutral’ territory the previous day. Message volume increased by 20% over 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_05_06_210536_png_b847bb27ce.webp" alt="BYND’s Sentiment Meter and Message Volume as of 21:00 p.m. ET on May. 6, 2026 | Source: Stocktwits" width="929" height="101"><figcaption>BYND’s Sentiment Meter and Message Volume as of 21:00 p.m. ET on May. 6, 2026 | Source: Stocktwits</figcaption></figure>Many retail traders appeared positive about Beyond Meat’s growth prospects.&nbsp;A user&nbsp;<a href="https://stocktwits.com/Guestthatrader/message/652538093">said</a>, “I’m glad I hold and I feel good about this trade…. This ticker was manipulated enough.”&nbsp;Another user&nbsp;<a href="https://stocktwits.com/silentfury/message/652537619">added</a>, “If you heard, he said the next quarter is typically better. So that means buy low and load and hold for gains in the future,” referring to CEO’s speech in the earnings call.&nbsp;A user mentioned that the company’s “turnaround” is in progress.&nbsp;<stembedurl>https://stocktwits.com/StockWienerdog/message/652535312</stembedurl>BYND stock has gained nearly 27% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-this-top-value-investor-is-advising-that-e-bay-should-not-sell-to-gamestop/cZQzNa5ReOy">Why This Top Value Investor Is Advising That eBay Should Not Sell To Gamestop</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Illustrated Beyond Meat, Jiangsu Province, China, August 9, 2023.

BYND Stock Plunges: Weak Outlook Overshadows First Positive Gross Margin In Years — Retail Loads Up Anyway

The company sees second-quarter revenue in the $60 million to $65 million range.

<ul class="summary-bullets"><li>The company announced a mid-June Falcon 9 launch for three BlueBird satellites ahead of earnings next week.</li><li>ASTS reiterated plans for launches every one to two months on average.</li><li>The firm also released a Texas factory tour video highlighting over 500,000 square feet of manufacturing capacity and ongoing satellite assembly operations.</li></ul>Shares of AST SpaceMobile (ASTS) jumped 4% in extended trading on Wednesday after the company unveiled a mid-June Falcon 9 launch plan and showcased its Texas manufacturing ramp, boosting investor optimism ahead of earnings next week.&nbsp;<a href="https://stocktwits.com/symbol/ASTS">ASTS stock</a> jumped 11% on Monday to end at $70.68, logging its best session in over a month.&nbsp;&nbsp;<h2 class="st-heading-2">Falcon 9 Launch Timeline Back In Focus</h2>Late Wednesday, AST SpaceMobile&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/AST_SpaceMobile/status/2052150788957622512">said on X</a> that three BlueBird satellites are scheduled for a mid-June launch aboard a Falcon 9 rocket. The company also said 32 next-gen satellites are already at advanced stages of assembly and reiterated plans for launches every one to two months on average as it expands its space-based cellular broadband network. The update comes after weeks of pressure on ASTS shares after last month’s failed BlueBird-7 mission and heavy selling from Rakuten Mobile.The latest development is likely to ease some fears that AST SpaceMobile’s satellite deployment plans had derailed after BlueBird-7 failed to reach its intended orbit during Blue Origin’s New Glenn Mission-3.&nbsp;At the time, AST SpaceMobile said BlueBird 8 through 10 were expected to be ready for shipment in “approximately 30 days.” While AST SpaceMobile did not explicitly reaffirm the original 30-day shipment target, the company focused on launch readiness, assembly progress and Falcon 9 deployment preparations.&nbsp;Alongside the launch update, AST SpaceMobile released a factory tour video highlighting large-scale production operations inside its Texas manufacturing unit. The video showed over 500,000 square feet of manufacturing capacity at full production and showed technicians assembling satellite structures across multiple production lines.&nbsp;<h2 class="st-heading-2">BlueBird-7 Failure Still Looms&nbsp;</h2>The latest update comes weeks after AST SpaceMobile confirmed BlueBird-7 had been placed into a lower-than-planned orbit and would eventually de-orbit despite successfully separating from the rocket and powering on. CEO Abel Avellan said the launch vehicle’s second stage failed to place the satellite into its intended orbit. The company said the satellite’s cost is expected to be recovered through insurance.The failed deployment triggered a sharp selloff in ASTS shares and intensified concerns around whether the company can still achieve its target of 45 satellites in orbit by year-end. However, Bank of America Securities estimates that the company could fall short of the target by about 7 satellites.&nbsp;<h2 class="st-heading-2">Rakuten Selling Ends Ahead Of Earnings</h2>Investors are also monitoring recent stake sales by Rakuten Mobile, AST SpaceMobile’s largest investor. A fresh filing from this week showed that Rakuten completed its previously disclosed trading plan and sold all shares from the program. The filing showed that Rakuten Mobile, alongside founder Hiroshi Mikitani and Rakuten Group, now own 15.5 million ASTS shares, representing a 5.3% stake in the company, down from 11% previously.&nbsp;The filing detailed multiple open-market sales between April 27 and May 5, including a 1.8 million share sale on April 30, with the final transactions executed at average prices around $65 per share.&nbsp;Wall Street now turns its attention to AST SpaceMobile’s first-quarter (Q1) earnings report due Monday. Fiscal AI estimates revenue of $40 million for the quarter, compared with $3.25 million a year earlier. Analysts expect a loss of $0.17 per share versus a loss of $0.21 last year. According to Koyfin data, analysts maintain an average 12-month price target of $86.4 on ASTS shares, implying a 22% upside from current levels.<h2 class="st-heading-2">How Do Retail Traders Feel About ASTS?</h2>On Stocktwits, retail sentiment for ASTS jumped to ‘bullish’ from ‘neutral’ levels a day ago amid ‘normal’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/asts_ss_png_d96be43951.webp" alt="asts ss.png" width="972" height="140"><figcaption>ASTS sentiment and message volume as of May 6 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/oldmacdonald/message/652535619">said</a>, “with earnings beat and a few more launches easily $120 again.”<stembedurl>https://stocktwits.com/oldmacdonald/message/652535619</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Eh514/message/652534849">said</a>, “Mid June [is] exactly when space x comes on. Hype will be great at see $150 easy.”<stembedurl>https://stocktwits.com/Eh514/message/652534849</stembedurl>ASTS stock has rocketed 182% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/billionaire-reid-hoffman-says-crypto-is-obvious-answer-for-ai-identity/cZQzW4IReOA">Billionaire Reid Hoffman Says Crypto Is ‘Obvious Answer’ For AI Identity – Hasn’t Sold Any Bitcoin Since 2014&nbsp;</a>

In this photo illustration, the AST SpaceMobile (Space Mobile) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ASTS Stock Jumps After-Hours: Falcon 9 Launch Push And End Of Rakuten Selling Lift Sentiment Before Earnings

ASTS said 32 next-gen satellites are already at advanced stages of assembly.

<ul class="summary-bullets"><li>Record quarterly revenue of $1.49 billion for the period ended March 31, 2026, representing 20% year-over-year growth.</li><li>Royalty revenue of $671 million, up 11% year-over-year, and license revenue of $819 million, surging 29% year-over-year.</li><li>Sees $2 billion worth of demand for a new in-house chip in fiscal years 2027 and 2028 combined, twice its previous estimate.</li></ul>ARM Holdings (ARM) stock gave up early gains and dropped 6% after-hours after the firm’s CEO flagged supply constraints to meet an additional $1 billion in demand for its new datacenter chip.&nbsp;&nbsp;&nbsp;The semiconductor stock’s adjusted earnings per share for the fiscal fourth quarter ending March were $0.60, ahead of Wall Street’s consensus estimate of $0.58 and up from $0.55 last year. Revenue for the quarter reached $1.49 billion, better than expectations of $1.47 billion, and up 20% on the year.Arm’s licensing revenue came in at $819 million, rising by 29% from last year, while its revenues from royalties grew at a slower pace of 11% to $671 million.Shares initially soared as much as 13% after-hours before giving up all the gains and more.&nbsp;The company said it expects $2 billion in demand for a new in-house datacenter-focused chip in fiscal years 2027 and 2028 combined, twice its previous estimate, but said it could secure supply only for $1 billion worth of chips.&nbsp;"Customer response to Arm AGI CPU has been strong. We now have more than $2 billion of customer demand across fiscal 2027 and fiscal 2028, more than double what we stated at launch," ARM top boss Rene Haas and finance chief Jason Child said in a shareholder letter.&nbsp;However, management confirmed on the earnings call that it had secured supply for the first $1 billion of demand. "For the $2 billion we are now in the process of securing supply to support that."&nbsp;&nbsp;ARM, along with its chipmaking peers like AMD, is seeing a strong rise in chip demand as the world continues to increase usage of AI services, which require high computational power.&nbsp;<h2 class="st-heading-2">ARM Guidance&nbsp;</h2>The company sees fiscal Q1 2027, ending in June, adjusted earnings of $0.40 per share, plus or minus $0.04 per share, on revenue of $1.26 billion, plus or minus $50 million. Analysts had expected a revenue of $1.25 billion.&nbsp;<h2 class="st-heading-2">ARM Retail View&nbsp;</h2>Retail sentiment on Stocktwits was ‘extremely bullish’ and message volumes were ‘extremely high’.&nbsp;One user highlighted how most chipmakers are choked by limited manufacturing capacities and opined that they should raise prices.&nbsp;<stembedurl>https://stocktwits.com/the_big_gains/message/652537024</stembedurl>The stock has soared 114% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The replica of the ARM is an electronic chip board during a collaborative ceremony launching a partnership between Malaysia and ARM Holdings in Kuala Lumpur, Malaysia, on March 5, 2025. 

ARM Stock Drops After CEO Flags Supply Risks That Could Dent New Semiconductor Chips Sales In Q1

ARM sees earnings per share soar to $9 per share in 2031.

<ul class="summary-bullets"><li>In March, Rivian announced three variants for the R2, called Standard, Premium, and Performance.</li><li>However, in an interview with Reuters, Rivian CEO RJ Scaringe reportedly said that the company is eyeing launching other variants.</li><li>The CEO did not disclose how the additional variants would look, Reuters noted.</li></ul> EV startup Rivian Automotive (RIVN) is on track to record its third consecutive week in the red despite reports that the company is working on undisclosed variants of its upcoming R2 midsize vehicle.Shares of the company fell 1% on Wednesday and nearly 4% this week, on the heels of recording a 9% drop last week when the firm reported first-quarter earnings and revenue which beat Wall Street estimates.Interestingly, RIVN stock closed most weeks in 2026 in the red, recording gains of over 4% in only three weeks.<h2 class="st-heading-2">New And Undisclosed R2 Variants</h2>In March, Rivian announced three variants for the R2, called Standard, Premium, and Performance. Rivian is slated to start deliveries of the top-end variant, priced around $58,000, around June. Deliveries of the other two variants will follow later this year, and in 2027, the company had said.However, in an <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/autos-transportation/rivian-developing-variants-its-more-affordable-r2-evs-2026-05-06/">interview </a>with Reuters, Rivian CEO RJ Scaringe reportedly said that the company is eyeing launching other variants. The CEO did not disclose how the additional variants would look, Reuters noted."So clearly there ​could be an ⁠R2X," CEO RJ Scaringe reportedly told Reuters. "There's going to be combinations," he noted, adding that he does not want to announce the program yet.<h2 class="st-heading-2">Rivian’s R2 Roadmap</h2>Rivian commenced production of the R2 SUV in April at its Normal, Illinois, facility. The new vehicle is aimed at expanding Rivian’s total addressable market with a price point much below its current R1 offerings, which have a starting price above $70,000. The standard variant of R2 will be priced around $45,000 to compete with Tesla’s best-selling Model Y SUV.For the whole of 2026, Rivian now expects to deliver 62,000-67,000 vehicles, up from the 42,247 vehicles delivered in 2025, thanks to the boost provided by R2. However, the ramp of R2 delivery will be “back-half weighted,” Rivian CFO Claire McDonough said last week.“As discussed previously, R2 production is starting with a single shift operation, and we expect to scale to 2 shifts by the end of 2026 as we ramp towards our North Star target of profitably delivering 4,000 vehicles per week in Normal,” McDonough said during the company’s first quarter earnings call.The CFO further highlighted that the new vehicle launch will negatively impact the company’s automotive gross profit in Q2 and Q3 before benefiting in Q4 as the company ramps production and deliveries. While Rivian started R2 production at its existing facility in Normal, the company expects that its upcoming facility in Georgia will provide added capacity in time.<h2 class="st-heading-2">How Did RIVN Retail Traders React?</h2>On Stocktwits, retail sentiment around RIVN stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed within ‘extremely high’ levels.A Stocktwits user voiced optimism for Rivian’s vehicle lineup and added that “there has never been a better time to buy” the stock.<stembedurl>https://www.stocktwits.com/Chewbanka/message/652532814</stembedurl><a href="https://stocktwits.com/symbol/RIVN">RIVN stock</a> has gained 7% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/spacexai-takes-off-elon-musk-consolidates-ai-empire-ahead-of-massive-ipo/cZQzjOQReOD">SpaceXAI Takes Off: Elon Musk Consolidates AI Empire Ahead Of Massive IPO</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Rivian R2 SUV is displayed during the Rivian Reveals All-Electric R2 Midsize SUV event.

RIVN On Track For Third Straight Week In The Red Despite CEO Teasing Fresh R2 Variants 

RIVN stock closed most weeks in 2026 in the red, recording gains of over 4% in only three weeks. 

<ul class="summary-bullets"><li>Earlier this year, Culper Research alleged channel stuffing and undisclosed related-party transactions at Adma.&nbsp;</li><li>Adma said on Wednesday that there is no evidence of any illegal activity at the company.&nbsp;</li><li>The firm also withdrew its previously issued long-term guidance.</li></ul>ADMA Biologics (ADMA) shares plunged 24% in after-hours trading on Wednesday following the release of disappointing first-quarter results that showed flat revenue and a sharp cut to full-year guidance amid intensifying competition in the U.S. immunoglobulin (IG) market.ADMA reported first-quarter 2026 total revenue of $114.5 million, essentially flat compared with $114.8 million in the year-ago period and well below Wall Street expectations of roughly $140 million.The top-line miss was driven by a steep decline in BIVIGAM sales, which fell 54% year-over-year to $15.4 million, while ASCENIV sales grew 28% to $97.5 million. Both ASCENIV and BIVIGAM are used to treat primary humoral immunodeficiency, a group of inherited disorders leading to low antibody production.Despite the revenue stall, profitability metrics improved markedly. Diluted earnings per share came in at $0.19, above the $0.11 reported in the corresponding quarter of 2025, and in line with Wall Street expectations.<h2 class="st-heading-2">Management Weighs In On Competition</h2>In a statement, President and CEO Adam Grossman acknowledged near-term challenges but emphasized underlying strength in ASCENIV demand.“During the first quarter, the market for U.S. plasma-derived therapies and immunoglobulin experienced increased competitive dynamics which, along with variability in distributor ordering patterns, created near-term topline pressures, particularly impacting BIVIGAM,” Grossman said.“Importantly, these dynamics were limited to distribution and inventory behavior and we believe do not reflect any deterioration in underlying ASCENIV demand, where fundamentals remained strong and continue to improve—with record utilization growth throughout the quarter.”Grossman described Q1 results as a likely “trough revenue baseline” caused by what the company views as a “temporary market dislocation.”<h2 class="st-heading-2">ADMA’s 2026 Guidance</h2>ADMA updated its 2026 financial outlook to reflect the evolving competitive landscape. The company now expects full-year revenue of $530 million to $560 million, down from prior guidance above $635 million, and adjusted core profit of $265 million to $300 million. It also withdrew its previously issued long-term guidance.The company attributed the softer outlook to sustained pricing pressure on standard IG products and changing competitive dynamics.<h2 class="st-heading-2">Short-Seller Report</h2>ADMA also addressed lingering investor concerns stemming from a Culper Research report earlier this year that <a href="https://stocktwits.com/news-articles/markets/equity/adma-stock-drops-after-culper-research-alleges-channel-stuffing/cZ3nq7uRI1i">alleged</a> channel stuffing and undisclosed related-party transactions. Culper alleged in a report that Adma’s reported growth is a “fiction driven more than entirely by a de facto channel stuffing scheme and an undisclosed related party distributor." Without the sales figure inflation, Culper estimated Adma's revenues declined 3% in 2025 as compared to the 20% growth reported.However, Adma said on Wednesday that its Audit Committee, assisted by independent forensic accountants and external counsel, completed a review and “concluded that ADMA has not engaged in any improper channel stuffing or any undisclosed related party transactions,” finding “no evidence of any illegal activity,” it said.<h2 class="st-heading-2">How Did ADMA Retail Traders React?</h2>On Stocktwits, retail sentiment around ADMA stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user said that investors who invest now at ‘peak negativity’ stand the chance to make a lot of money.<stembedurl>https://www.stocktwits.com/david999957/message/652525861</stembedurl>Another opined that it is just a “terrible luck” year for the company with the short seller report and market dislocation for Bivigam.<stembedurl>https://www.stocktwits.com/azv134/message/652522379</stembedurl><a href="https://stocktwits.com/symbol/ADMA">ADMA stock</a> has fallen 56% over the past 12 months. &nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/srpt-stock-plunges-after-hours-as-elevidys-demand-slumps-ceo-still-sees-return-to-growth/cZQzkcWReOx">SRPT Stock Plunges 7% After-Hours As Elevidys Demand Slumps — CEO Still Sees Return To Growth</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ADMA Biologics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds  

In a statement, President and CEO Adam Grossman acknowledged near-term challenges but emphasized underlying strength in its therapy ASCENIV’s demand.

<ul class="summary-bullets"><li>GameStop CEO Ryan Cohen offered $56 billion, or $125 per share, to acquire eBay.</li><li>GME is planning to buy eBay using $9 billion cash, $20 billion debt, and new stock.</li><li>Smead Capital Management sees no reason for eBay to sell to GME.</li></ul>GameStop (GME) CEO Ryan Cohen’s unsolicited proposal to acquire eBay is drawing skepticism from Wall Street, including long-time eBay shareholder Smead Capital Management.&nbsp;Prominent money manager Bill Smead, whose firm has been an eBay stakeholder for nearly 20 years, is skeptical about how GME will be able to afford the deal, with eBay stock hovering around $108.&nbsp;“I don’t see any reason for eBay to sell to GameStop,” Smead, who is his firm’s chief investment officer, told Barron’s in an interview.&nbsp;Smead Capital Management, which Smead founded, owned about 1.5 million shares of eBay in the Smead Value Fund as of the end of the first quarter, a stake now worth nearly $160 million. Smead said he has owned eBay in the fund since its inception in 2008.&nbsp;GameStop’s market valuation is about $11 billion, while the takeover bid values eBay at&nbsp;about $56 billion, and investors are confused about how Cohen can afford the acquisition.&nbsp;Of the $56 billion, GameStop has about $30 billion lined up,&nbsp;including more than $9 billion in cash on its balance sheet and a $20 billion debt financing commitment from TD Securities, according to Barron’s. In an interview on Monday on CNBC, Cohen said GameStop could get the deal done by issuing more stock.&nbsp;Earlier during the day, Cohen took to X with a tongue-in-cheek response to skeptics.“I’m selling stuff on eBay to pay for eBay,” Cohen posted on X, alongside a link to his personal seller account.<h2 class="st-heading-2">Smead’s Commentary</h2>Smead told Barron’s that if GameStop had a “legitimate offer” to buy eBay for $125 a share, eBay should consider it.Still, he said, eBay shouldn’t be in a hurry to sell itself since it is doing just fine on its own.Smead described eBay as “the New York Stock Exchange of preowned items,” raking in ‘‘loads of money” from transaction fees.<h2 class="st-heading-2">Retail View On eBay And GME</h2>On Stocktwits, retail sentiment around GME and EBAY stocks stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.&nbsp;One user&nbsp;urged not to let Cohen near eBay.<stembedurl>https://stocktwits.com/MomchilB/message/652523039</stembedurl>While&nbsp;<a href="https://stocktwits.com/symbol/EBAY">EBAY stock</a> has gained 54% over the past 12 months,&nbsp;<a href="https://stocktwits.com/symbol/GME">GME shares</a> dropped 3%.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

In this photo illustration, a smartphone displays the eBay logo, with GameStop branding visible in the background

Why This Top Value Investor Is Advising That eBay Should Not Sell To Gamestop

Bill Smeade, chief investment officer of Smead Capital Management, thinks eBay should not be in a hurry to sell itself.

Bill Smead, chief investment officer of Smead Capital Management, thinks eBay should not be in a hurry to sell itself.

<ul class="summary-bullets"><li>Sees revenue between $1.52 billion and $1.55 billion in the period ending in June.&nbsp;</li><li>Geopolitics in the Middle East had a negative impact on&nbsp;Snap’s advertising business.</li><li>Reports Q1 loss of $0.05 while analysts expected a profit of $0.10.</li></ul>Snap Inc (SNAP) share price dropped 6% after-hours after the social media firm flagged a $20 million to $25 million hit to its advertising revenues due to geopolitical pressures in the Middle-East during the quarter ending March.&nbsp;Advertising revenue rose 3% to $1.24 billion, predominantly driven by paid ads. The company said it had an estimated $20 million to $25 million impact from the ​Middle East conflict during the first quarter.&nbsp;Snap reported 483 million daily ‌active ⁠users (DAU) in the first quarter, adding 9 million from the prior quarter. But DAUs in North America declined, while revenue growth in the region slowed to 2%.“In Q1, we returned to growth in daily active users, accelerated revenue growth, expanded margins, and generated strong free cash flow,” Snap CEO Evan Spiegel said in a statement.The company said in an investor letter that “large advertisers in North America remained a headwind to advertising growth” in the first quarter, and while the company is “not satisfied with that outcome,” it is “beginning to see encouraging signs that this part of the business is improving.”Snap has been struggling to cope with the scale at which its rivals - Meta’s Instagram and China’s TikTok - have been growing, finding it difficult to garner more advertiser interest.&nbsp;<h2 class="st-heading-2">SNAP Perplexity Deal Falls Apart&nbsp;</h2>California-based Snap officially ended its artificial intelligence partnership with Perplexity AI&nbsp;in the quarter.&nbsp;The company said in the investor letter that its sales guidance “assumes no contribution from Perplexity as we amicably ended the relationship in Q1,” referring to the $400 million deal it announced in November with the generative AI startup.&nbsp;Snap also mentioned in the letter that "Nearly ​70% of advertising spend now uses at least one of our ​AI-powered automation ⁠solutions."&nbsp;<h2 class="st-heading-2">SNAP Q2 Guidance</h2>Snap said second-quarter sales will be in the range of $1.52 billion to $1.55 billion, roughly in line with analyst estimates of $1.54 billion&nbsp;at the midpoint, as per data from&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://fiscal.ai">Fiscal.ai</a>.<h2 class="st-heading-2">SNAP Retail View&nbsp;</h2>However, retail sentiment on Stocktwits was ‘bullish’ with ‘high’ message volumes.&nbsp;One user felt the company CEO’s vision is increasingly getting “disconnected from reality.”<stembedurl>https://stocktwits.com/Stonks4us/message/652528598</stembedurl>The stock has lost 24% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Snap Inc. (NYSE: SNAP), the parent company of Snapchat, on July 31, 2025, in Chongqing, China. 

SNAP Stock Tumbles After Flagging Ad Revenue Hit Amid Iran War

Snap ended the $400 million deal with Perplexity during the first quarter.

<ul class="summary-bullets"><li>SRPT’s Q1 revenue and earnings beat Wall Street expectations.&nbsp;</li><li>FDA-approved Elevidys came under scrutiny last year over concerns of acute liver failure and associated patient deaths.</li><li>Sarepta CEO Doug Ingram, however, struck an optimistic tone, saying that the company’s commercial portfolio has “begun to stabilize” and that Elevidys “is positioned to return to growth.”</li></ul> Shares of Sarepta Therapeutics Inc. (SRPT) fell 7% in after-hours trading on Wednesday after the company reported first-quarter 2026 results that beat Wall Street expectations on both revenue and earnings but highlighted ongoing softness in its flagship gene therapy Elevidys.The Cambridge-based biotech posted total revenue of $730.8 million, down 2% year-over-year but topping consensus estimates of roughly $475.01 million. Adjusted earnings per share for the three months ended March came in at $3.16, compared to a loss of $3.42 reported in the corresponding quarter of 2025, and comfortably above an analyst estimate of $1.09 in earnings per share.Net product revenue came in at $330.5 million, with Elevidys, Sarepta’s one-time gene therapy for Duchenne muscular dystrophy (DMD), generating $102 million in net product sales, down from the $375 million record in Q1 2025. The lowered Elevidys sales reflect the limitation of the drug’s addressable population to DMD patients who can walk following safety concerns flagged last year. &nbsp;Sarepta reiterated its full-year 2026 guidance for total net product revenue of $1.2 billion to $1.4 billion. Cash, cash equivalents, restricted cash and investments stood at $748.3 million at quarter-end.Sarepta CEO Doug Ingram, however, struck an optimistic tone, saying that the company’s commercial portfolio has “begun to stabilize” and that Elevidys “is positioned to return to growth.”FDA-approved Elevidys came under scrutiny last year over concerns of acute liver failure and associated patient deaths. While the company resumed shipments to patients who can walk after a temporary pause in shipments in July 2025, it is now working to address safety concerns in patients who cannot walk.The company is currently undertaking studies to develop a regimen that makes the therapy safe and usable in non-ambulatory patients by pretreating them with the immunosuppressant medication sirolimus before administering Elevidys. Sirolimus is commonly used to prevent organ rejection in kidney transplant patients.<h2 class="st-heading-2">How Did SRPT Retail Traders React?</h2>On Stocktwits, retail sentiment around SRPT stock jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels.A Stocktwits user opined that basic demand was never there for Elevidys.<stembedurl>https://www.stocktwits.com/LikesVikes/message/652520772</stembedurl>Another user dismissed the “short-term price reactions” and said they are going to hold on to the stock for a “long, long time.”<stembedurl>https://www.stocktwits.com/Dondetzela/message/652519939</stembedurl><a href="https://stocktwits.com/symbol/SRPT">SRPT stock</a> has fallen by about 51% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/spacexai-takes-off-elon-musk-consolidates-ai-empire-ahead-of-massive-ipo/cZQzjOQReOD">SpaceXAI Takes Off: Elon Musk Consolidates AI Empire Ahead Of Massive IPO</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Sarepta Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

SRPT Stock Plunges 7% After-Hours As Elevidys Demand Slumps — CEO Still Sees Return To Growth

The stock was weighed down after hours by lower sales reported for Sarepta’s gene therapy Elevidys. 

<ul class="summary-bullets"><li>Musk’s announcement signals a deeper consolidation of his AI and space businesses.</li><li>SpaceX acquired xAI in February earlier this year in an all-stock transaction.&nbsp;</li><li>SpaceX’s AI roadmap centers on moving large-scale compute infrastructure off Earth entirely.</li></ul>Billionaire entrepreneur Elon Musk announced Wednesday that his artificial intelligence startup xAI will be dissolved as a standalone company and fully integrated into SpaceX, rebranding its AI efforts as SpaceXAI. &nbsp;The move, posted on X, comes hours after SpaceX and xAI revealed a major compute-sharing agreement with Anthropic. Under the deal, Anthropic will gain access to the capacity of SpaceX’s Colossus 1 supercomputer in Memphis — a cluster of more than 220,000 NVIDIA GPUs — to expand Claude Pro and Claude Max usage limits.Anthropic also expressed interest in partnering on “multiple gigawatts of orbital AI compute capacity,” citing the physical limits of terrestrial power, land, and cooling for next-generation AI systems.“xAI will be dissolved as a separate company, so it will just be SpaceXAI, the AI products from SpaceX,” Musk said in a post on X.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/2052105373621121284?s=20"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_05_06_171950_png_5e24dd46ac.webp" alt="Screenshot 2026-05-06 171950.png"></a><h2 class="st-heading-2">Consolidation Within Musk Empire</h2>Musk’s announcement signals a deeper consolidation of his AI and space businesses. SpaceX had already absorbed xAI in a formal acquisition earlier this year, but the new “SpaceXAI” framing underscores that all AI development will now operate directly under the SpaceX umbrella.SpaceX’s AI roadmap centers on moving large-scale compute infrastructure off Earth entirely. Musk and the company have repeatedly stated that space-based data centers — powered by near-constant solar energy and cooled in the vacuum of space — represent the only sustainable path to meet exploding AI energy demands.Key elements of the plan include deploying massive constellations of AI-capable satellites that function as orbiting supercomputers and using the Starship launch vehicle’s payload capacity to launch the heavy infrastructure required for orbital data centers. SpaceX’s long-term plans include lunar AI satellite factories and even broader solar-system-scale expansion to support Moon bases, Mars colonization, and eventual multi-planetary civilization.<h2 class="st-heading-2">Upcoming IPO</h2>The integration and orbital AI push come as SpaceX prepares for one of the largest initial public offerings in history. The company is targeting a mid-2026 IPO — possibly as early as June — with valuations discussed in the $1.75 trillion to $2 trillion range.On Stocktwits, retail sentiment around SPACEX trended in the ‘neutral’ territory, coupled with ‘low’ message volume.An X user wondered what the ticker for SpaceX would be after the rebrand and an IPO.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/ThaoJennif66601/status/2052105507662688517?s=20"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_05_06_172635_png_7728b1d709.webp" alt="Screenshot 2026-05-06 172635.png"></a>Yet another opined that combining the two companies’ capabilities would “unlock some seriously powerful synergies.”<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Rooh_Ullah1/status/2052107789380866293?s=20"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_05_06_172743_png_14ada78088.webp" alt="Screenshot 2026-05-06 172743.png"></a>Some users also speculated what the combined company’s new logo will look like.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/AdamLowisz/status/2052106404605948286?s=20"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_05_06_171840_png_d99528081c.webp" alt="Screenshot 2026-05-06 171840.png"></a>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/gamestop-ceo-auctions-mug-hate-more-to-fund-ebay-takeover/cZQziakReOv">Cohen’s eBay Fire Sale: Gamestop CEO Auctions Mug, Hat and More To Fund eBay Takeover</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The SpaceX logo is displayed on a smartphone screen with the xAI logo in the background.

SpaceXAI Takes Off: Elon Musk Consolidates AI Empire Ahead Of Massive IPO

The move, posted on X, comes hours after SpaceX and xAI revealed a major compute-sharing agreement with Anthropic.

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as investors position themselves ahead of the upcoming earnings release, with discussions centering on the company's progress under new leadership and potential for a breakout. Enthusiastic retail participants are debating the impact of strategic housing market initiatives and tracking sentiment against bearish short-interest concerns.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending due to heightened community anticipation ahead of its upcoming earnings report, with investors weighing concerns over North American user growth against a growing narrative of improved operational efficiency and potential AI-driven monetization. Discussions are polarized, as some shareholders focus on long-term turnaround potential through cost-cutting and hardware innovation, while others remain critical of management and historical performance.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently in the spotlight as investors weigh its aggressive expansion into the data center CPU market against concerns over supply constraints and high valuation. While the community remains divided over the sustainability of its rapid growth, there is significant active discussion regarding its shift toward becoming a cornerstone of AI infrastructure.

Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Axe Compute Inc.

Axe Compute Inc. Common Stock

Axe Compute Inc. is trending following the announcement of a significant multi-year enterprise contract to deploy Nvidia hardware, fueling community speculation about the company's valuation and revenue potential. While some investors are bullish on the AI infrastructure narrative and recent insider activity, others are actively debating potential dilution risks and the stock's high volatility.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is gaining market attention ahead of the upcoming Warner Bros. Discovery shareholder vote, as investors weigh the potential of the combined media giant against ongoing regulatory scrutiny and industry backlash. Community discussion is focused on the strategic integration of content libraries, the impact of potential warrants, and speculation regarding executive leadership's political connections.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently the center of intense debate following a short-seller report that triggered a sharp selloff, despite the company's aggressive rebuttal and a massive share buyback program. Investors are actively split between those who view the current price as a generational buying opportunity based on strong ASCENIV demand and pending label expansions, and those who remain skeptical due to the withdrawal of long-term guidance and ongoing competitive headwinds.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are experiencing extreme volatility and intense community debate following a blowout earnings report that featured massive revenue growth, doubled net income, and aggressive buybacks. Investors are currently clashing over whether the stock is a long-term profit machine suffering from short-term manipulation or a overextended play facing risks from a recent mixed shelf offering filing and broader software sector weakness.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is trending as the community closely monitors its recent $625 million acquisition of Mirantis and anticipates upcoming earnings, fueling debates over the company's shift toward a full-stack AI cloud model. Investors are actively discussing the potential for major hyperscaler contract announcements and whether this move effectively bridges the gap in their AI software capabilities.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is rallying as investors shift their focus toward commercial scaling, fueled by recent high-profile partnerships and optimism surrounding its autonomous trucking technology. The community is actively discussing the stock's significant short interest and the potential for a squeeze, while balancing excitement for upcoming earnings and milestone updates against concerns over long-term capital needs and dilution.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing heightened investor debate as the stock faces downward pressure near 52-week lows, fueling community speculation about institutional manipulation versus legitimate concerns over competitive headwinds and integration noise. Investors are closely monitoring the upcoming earnings announcement for signs of a turnaround, with bullish sentiment anchored by long-term growth prospects, strong brand loyalty, and the potential for a post-earnings recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
